Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Approves Mucinex DM Tablets for Over-the-Counter Sales

By Pharmaceutical Processing | May 17, 2004

CHESTER, NJ (May 17, 2004) – The U.S. Food & Drug Administration (FDA) last week gave Adams Respiratory Therapeutics the go-ahead to begin selling its Mucinex cough medicine over the counter. Adams is expected to begin marketing the drug in nationwide pharmacies in September.

‘ The FDA approval is for Mucinex DM in two strengths, extended release guaifenesin 600 mg/dextromethorphan HBr 30 mg and guaifenesin 1200 mg/dextromethorphan HBr 60 mg.

The move represents the first FDA approval of an extended release combination product containing guaifenesin and dextromethorphan, according to the company. Such products have previously been available by prescription only. In July 2002, Adams received FDA approval for Mucinex extended release guaifenisin 600/1200 mg.

The company has also filed a New Drug Application and has received an approvable letter for Mucinex D extended release guaifenesin 600 mg/pseudoephedrine 60 mg and guaifenesin 1200 mg/pseudoephedrine 120 mg, the company said.

Adams Respiratory Therapeutics develops, markets and sells prescription and non-prescription pharmaceuticals for the treatment of respiratory disorders and diseases.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE